4.5 Article

Characteristics of myotonic dystrophy patients in the national registry of Japan

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Metabolic complications in myotonic dystrophy type 1: A cross-sectional survey using the National Registry of Japan

Manami Hama et al.

Summary: Myotonic dystrophy type 1 (DM1) is the most common form of muscular dystrophy in adults, affecting multiple organs, but metabolic disturbances, such as liver dysfunction, dyslipidemia, and impaired glucose tolerance, are less explored despite their significant prevalence in DM1 patients. More research and management strategies are needed in this area.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2021)

Article Clinical Neurology

The Canadian Neuromuscular Disease Registry 2010-2019: A Decade of Facilitating Clinical Research Through a Nationwide, Pan-Neuromuscular Disease Registry

V Hodgkinson et al.

Summary: The Canadian Neuromuscular Disease Registry (CNDR) has successfully registered 4306 patients with 91 different neuromuscular diagnoses since 2010, facilitating 125 projects and proving to be an effective and productive registry for neuromuscular diseases.

JOURNAL OF NEUROMUSCULAR DISEASES (2021)

Article Biochemistry & Molecular Biology

Allele length of the DMPK CTG repeat is a predictor of progressive myotonic dystrophy type 1 phenotypes

Gayle Overend et al.

HUMAN MOLECULAR GENETICS (2019)

Article Clinical Neurology

The myotonic dystrophy experience: a North American cross-sectional study

Katharine A. Hagerman et al.

MUSCLE & NERVE (2019)

Review Neurosciences

Molecular genetics of congenital myotonic dystrophy

Stella Lanni et al.

NEUROBIOLOGY OF DISEASE (2019)

Review Clinical Neurology

Respiratory dysfunction in myotonic dystrophy type 1: A systematic review

A. M. Hawkins et al.

NEUROMUSCULAR DISORDERS (2019)

Article Clinical Neurology

Cognitive impairment and quality of life in patients with myotonic dystrophy type 1

Haruo Fujino et al.

MUSCLE & NERVE (2018)

Article Clinical Neurology

A 9-year follow-up study of quantitative muscle strength changes in myotonic dystrophy type 1

Cynthia Gagnon et al.

JOURNAL OF NEUROLOGY (2018)

Article Clinical Neurology

Distribution and Structure of DM2 Repeat Tract Alleles in the German Population

Alexis S. Mahyera et al.

FRONTIERS IN NEUROLOGY (2018)

Review Clinical Neurology

Myotonic Dystrophies: Targeting Therapies for Multisystem Disease

Samantha LoRusso et al.

NEUROTHERAPEUTICS (2018)

Article Clinical Neurology

The UK Myotonic Dystrophy Patient Registry: facilitating and accelerating clinical research

Libby Wood et al.

JOURNAL OF NEUROLOGY (2017)

Article Clinical Neurology

A REVIEW OF MUSCLE-AND PERFORMANCE-BASED ASSESSMENT INSTRUMENTS IN DM1

Tara Symonds et al.

MUSCLE & NERVE (2017)

Article Clinical Neurology

Relationships between grip strength, myotonia, and CTG expansion in myotonic dystrophy type 1

Jean-Yves Hogrel et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2017)

Article Cardiac & Cardiovascular Systems

Population-based values and abnormalities of the electrocardiogram in the general Dutch population: The LifeLines Cohort Study

M. Yldau van der Ende et al.

CLINICAL CARDIOLOGY (2017)

Article Clinical Neurology

A Systematic Review and Meta-analysis on the Epidemiology of the Muscular Dystrophies

Jean K. Mah et al.

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2016)

Article Clinical Neurology

Parent-reported multi-national study of the impact of congenital and childhood onset myotonic dystrophy

Nicholas E. Johnson et al.

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2016)

Article Cardiac & Cardiovascular Systems

Association of Age, Sex, Body Size and Ethnicity with Electrocardiographic Values in Community-based Older Asian Adults

Eugene S. J. Tan et al.

HEART LUNG AND CIRCULATION (2016)

Article Clinical Neurology

Design, set-up and utility of the UK facioscapulohumeral muscular dystrophy patient registry

Teresinha Evangelista et al.

JOURNAL OF NEUROLOGY (2016)

Review Clinical Neurology

Myotonic dystrophy: diagnosis, management and new therapies

Chris Turner et al.

CURRENT OPINION IN NEUROLOGY (2014)

Article Clinical Neurology

Epiretinal membrane: a treatable cause of visual disability in myotonic dystrophy type 1

Hannah M. Kersten et al.

JOURNAL OF NEUROLOGY (2014)

Review Public, Environmental & Occupational Health

Prevalence of Muscular Dystrophies: A Systematic Literature Review

Alice Theadom et al.

NEUROEPIDEMIOLOGY (2014)

Article Genetics & Heredity

Nationwide patient registry for GNE myopathy in Japan

Madoka Mori-Yoshimura et al.

ORPHANET JOURNAL OF RARE DISEASES (2014)

Article Clinical Neurology

Fatigue and daytime sleepiness scale in myotonic dystrophy type 1

Mieke C. E. Hermans et al.

MUSCLE & NERVE (2013)

Article Clinical Neurology

Psychiatric and cognitive phenotype of childhood myotonic dystrophy type 1

Marie Douniol et al.

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2012)

Letter Genetics & Heredity

Myotonic dystrophy type 2 is rare in the Japanese population

Tohru Matsuura et al.

JOURNAL OF HUMAN GENETICS (2012)

Review Clinical Neurology

The myotonic dystrophies: molecular, clinical, and therapeutic challenges

Bjarne Udd et al.

LANCET NEUROLOGY (2012)

Article Clinical Neurology

Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1)

Chad Heatwole et al.

NEUROLOGY (2012)

Article Biochemistry & Molecular Biology

Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland

Tiina Suominen et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2011)

Article Clinical Neurology

Fatigue and daytime sleepiness in patients with myotonic dystrophy type 1: To lump or split?

Luc Laberge et al.

NEUROMUSCULAR DISORDERS (2009)

Article Cardiac & Cardiovascular Systems

Severity of cardiac conduction involvement and arrhythmias in myotonic dystrophy type 1 correlates with age and CTG repeat length

WJ Groh et al.

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2002)